ALS Canada VP, Research. Passionate ALS research nerd since 2001. Science brain, advocate heart. Opinions are my own. he/him
Joined March 2021
- Tweets3K
- Following1K
- Followers1.3K
- Likes5.6K
David Taylor retweeted
Help shape MND/ALS research! 🧠 LifeArc’s new survey focuses on tech to improve daily life with MND. Last time, @lifearc1 received 200 responses—thank you! 🙏
📢 If you have MND/ALS, care for someone, or are at risk, your input is crucial. @lifearc1
What technology could help improve daily life for those living with #MND?
We'd like to better understand the daily challenges to guide the development of new technologies and inform our future research and investment.
Share your thoughts in our survey: t.ly/hQTI_
David Taylor retweeted
🪣 The Ice Bucket Challenge was a giant leap forward for understanding ALS/MND. To mark the 10th anniversary of the challenge, we've created a special video. Thank you to @biogen for supporting this video.🙏 youtu.be/P4uBp-POT1o?si=fngP…
#EveryAugustUntilCure #ALSMNDWithoutBorders
David Taylor retweeted
Celebrate the 10th anniversary of the #ALSIceBucketChallenge and take the plunge with ALS Canada! 🧊🎉
Ten years ago today, Aug. 6, to Dec. 31, 2014, over 260k Canadians took part in the Ice Bucket Challenge, raising awareness and $17.2 million for #ALS. Take on the challenge again and tag ALS Canada - or donate today and invest in Canadian ALS research and support Canadians living with ALS: bit.ly/4dmdpM1.
This programme is awesome. If you are eligible (not just UK!), please consider it.
#ScienceCommunication can help you see the impact of your research. 🔬
Join us as a Symposium Communications Ambassador and hone your skills in communicating complex research through:
📱Social media
⌨️ Blogs
📹 Interviews
Apply: symposium.mndassociation.org…
#alsmndsymp #ecrchat
ALT Symposium communications ambassador programme! Help share the latest ALS/MND research with the wider community. The programme: - Training in lay writing, social media and video interviews - Raise your profile - Develop new connections - 50% symposium registration discount Deadline: 16 August 2024
David Taylor retweeted
“It’s easy to go and sit in the lab, and get good at science, but unless you can communicate that science there’s no point having done it.”
#MNDEnCouRageUK aims to give #MND #ALS early career researchers the skills to communicate their research to the people it matters most – people affected by the disease.
Read more: mndresearch.blog/2024/07/18/…
David Taylor retweeted
Are you an early career #MND #ALS researcher? Attending #alsmndsymp? Want to develop your science communication skills?
Apply to be a Symposium Communications Ambassador and help us share the latest research from the largest conference dedicated to ALS/MND!
More info: symposium.mndassociation.org…
ALT Symposium Communications Ambassador Programme Help share the latest ALS/MND research with the wider community The programme: Training in lay writing, social media and video interviews Raise your profile Develop new connections
David Taylor retweeted
Excited to share our reseach and connect with broader ALS research and patient community at the upcoming ALS Nexus conference hosted by the @alsassociation next week! @CRCHUM @UMontreal @packardcenter
David Taylor retweeted
A selection of our TDP-REG vectors are now available on Addgene! addgene.org/browse/article/2…
If you follow @mndassoc I’d imagine there is a good chance you might also want to follow their Research Team @mndresearch. You may not be aware that they have this new account & you would be missing all the great information they provide!
David Taylor retweeted
Showcase your community’s power and passion for change at the ALS Canada #PullToEndALS! 💪 Rise to the challenge with your team to help build awareness of #ALS and do more for individuals and families living with ALS. Register your team today, visit bit.ly/3x1JKs3.
Follow the new MND Research account @mndresearch. Easily one of the best sources of ALS/MND research information in the world.
David Taylor retweeted
✨ We’re back! ✨
You may have noticed we went quiet for a couple of weeks. But we are back posting about the latest and most exciting #MND #ALS research. 🔬
You also may notice that you’re no longer following us, please check so you continue to get the latest updates!
ALT 3 researchers wearing MND Association branded lab coats looking a book while in a laboratory
David Taylor retweeted
Follow @MNDResearch trusted source of MND/ALS information
✨ We’re back! ✨
You may have noticed we went quiet for a couple of weeks. But we are back posting about the latest and most exciting #MND #ALS research. 🔬
You also may notice that you’re no longer following us, please check so you continue to get the latest updates!
ALT 3 researchers wearing MND Association branded lab coats looking a book while in a laboratory
David Taylor retweeted
Developing the next generation of researchers is vital in the fight against #MND #ALS. 👨🔬
They may hold the cure in their hands, but they just don’t know it yet.
Next week we are holding #MNDEnCouRageUK to encourage, train and support the future MND research leaders.
Watch below to hear what delegates thought of last year's event! ⬇️
#ResearchAppreciationDay
David Taylor retweeted
Join my team at @kingsmnd @KingsIoPPN for a unique opportunity as a Research Fellow in #Epigenetics!
Be part of an exciting project: Validate new treatment targets for ALS/MND by evaluating methylation targets. Collaborate with biologists on wet lab experiments. Plus, work alongside @AmmarAlChalabi @AlfredoIacoange
Closing date: July 17, 2024. 🧠⚡🧬 #Epigenetics #ALS #neuroscience
This Post is from an account that no longer exists. Learn more
David Taylor retweeted
The ALS Canada - @BrainCanada Career Transition Award gives a boost to rising stars pursuing innovative #ALS research in their transition to an independent academic position. Applications are open until August 19, 2024 at 1:00 pm ET. Apply now: bit.ly/4aRP1l1.
The next chapter of the story from the UNC13A cryptic exon discoveries in Nature 2022. Easily the most scientifically interesting therapeutic target we have right now.
We find TDP-43 loss to cause presynaptic defects, which are rescued by ASOs correcting a single cryptic exon in UNC13A.
Surprising effect of just one cryptic exon and promising strategy for ALS!
Matt Keuss @PeteHarley95 in great collaboration with @jbneuro
biorxiv.org/content/10.1101/…
